Stocktoria

Iterum Therapeutics plc ITRMF

OTC · stock · Pharmaceutical Preparations · website · IPO 2018-05-25

Iterum Therapeutics plc (ITRMF) earns a Piotroski F-score of 1/9 (weak financial health). It does not currently pay a dividend.

1/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$0.05 as of 2026-06-01 · -95% 1y
$0.03$1.0052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Revenue trend · last 5y · down

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 1%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 1/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
ITRMFIterum Therapeutics plc1/9
JNJJOHNSON & JOHNSON4/922.9+6%
LLYELI LILLY & Co7/955.1+44.7%
MRKMerck & Co., Inc.4/917.4+1.3%
PFEPFIZER INC4/917.8-1.6%
ABBVAbbVie Inc.7/9-0.34105.9+8.6%
BMYBRISTOL MYERS SQUIBB CO7/916.7-0.2%

All Manufacturing companies →

FAQ

Is ITRMF financially healthy?

Iterum Therapeutics plc's Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak).

Does ITRMF pay a dividend?

No, Iterum Therapeutics plc does not currently pay a dividend.

Source: SEC EDGAR filings · CIK 0001659323 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.